| human | Q5 |
| P227 | GND ID | 1255215364 |
| P496 | ORCID iD | 0000-0002-8264-3856 |
| P1053 | ResearcherID | I-4864-2012 |
| P1153 | Scopus author ID | 14064102000 |
| P214 | VIAF ID | 1544165060298432740001 |
| P108 | employer | Unidade Local de Saúde de Coimbra | Q30675117 |
| P735 | given name | Carlos | Q364753 |
| Carlos | Q364753 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q28355722 | ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle |
| Q47729267 | Asthma-COPD overlap: A Portuguese survey |
| Q38779963 | Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA. |
| Q57175104 | COPD exacerbations: management and hospital discharge |
| Q51622539 | Caffeine consumption and exacerbations of chronic obstructive pulmonary disease: retrospective study. |
| Q90291712 | Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us? |
| Q38194728 | Consensus document for the prevention of respiratory infections in adults. |
| Q38915347 | Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. |
| Q50855057 | Environmental tobacco smoke exposure at home and smoking prevalence in the general Portuguese population--the INAsma study. |
| Q42320566 | Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). |
| Q38698587 | Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence. |
| Q87410006 | Love is not thanked |
| Q47667195 | Migration, TB control and elimination: Whom to screen and treat. |
| Q36024006 | Multicentric Genome-Wide Association Study for Primary Spontaneous Pneumothorax |
| Q85780448 | Nanoparticles, nanotechnology and pulmonary nanotoxicology |
| Q47890546 | Obstructive sleep apnoea syndrome is an under-recognized cause of uncontrolled asthma across the life cycle. |
| Q34062198 | Operational definitions of asthma in recent epidemiological studies are inconsistent |
| Q38665948 | Optimal treatment sequence in COPD: Can a consensus be found? |
| Q60446455 | Organizing Pneumonia due to Actinomycosis: An Undescribed Association |
| Q48960072 | Portugal at the cross road of international chronic respiratory programmes |
| Q122983094 | Rhinitis associated with asthma is distinct from rhinitis alone: The |
| Q51161148 | Selected clinical highlights from the 2010 ERS Congress in Barcelona. |
| Q61894840 | Should we use gait speed in COPD, FEV1in frailty and dyspnoea in both? |
| Q82741881 | Smoking-related lung diseases: a clinical perspective |
| Q93376382 | The European Respiratory Society's 10 Principles for Lung Health |
| Q91467495 | The European Respiratory Society: ensuring excellence through education best practice |
| Q35344151 | Towards tuberculosis elimination: an action framework for low-incidence countries |
| Q40165178 | Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project). |
| Q84643222 | What can we make with this national programme? |
| Q45893837 | …And I would say thank you so much and see you soon! |
Search more.